Good's Syndrome with Pneumocystis Jiroveci Lymphadenitis and Pure Red Cell Aplasia

Year 2016, Volume: 6 Issue: 2 - J Microbiol Infect Dis 2016; 06(02) June Issue, 87 - 91, 01.06.2016

Jintana Srisompong Torpong Thongngarm

https://doi.org/10.5799/jmid.328809

Abstract

Pneumocystis jiroveci lymphadenitis is a rare manifestation of extrapulmonary pneumocystosis. A case of recurrent
infection with lymphadenitis caused by Pneumocystis jiroveci in a middle-aged patient is described. He presented with
prolonged fever, recurrent diarrhea, and severe anemia required frequent blood transfusion recognized to be Good’s
syndrome. Cervical lymph node biopsy revealed caseating granulomas and presence of organisms morphologically
consistent with Pneumocystis spp. Bone marrow biopsy was compatible with pure red cell aplasia associated with Good’s
syndrome. According to our knowledge, it is the first case diagnosed with Good’s syndrome, Pneumocystis jiroveci
lymphadenitis and pure red cell aplasia. J Microbiol Infect Dis 2016;6(2): 87-91   

Keywords

Good’s syndrome, Pneumocystis jiroveci Lymphadenitis, Pure Red Cell Aplasia

References

• 1. Kelesidis T, Yang O. Good’s syndrome remains a mystery after 55 years: A systematic review of the scientific evidence. Clinical immunology (Orlando, Fla). 2010;135:347-363.
• 2. Ng VL, Yajko DM, Hadley WK. Extrapulmonary pneumocystosis. Clin Microbiol Rev. 1997;10:401-418.
• 3. Tasaka S, Tokuda H. Pneumocystis jirovecii pneumonia in non-HIV-infected patients in the era of novel immunosuppressive therapies. J Infect Chemother. 2012;18:793-806.
• 4. Thongprayoon C, Tantrachoti P, Phatharacharukul P, et al. Associated immunological disorders and cellular immune dysfunction in thymoma: a study of 87 cases from Thailand. Arch Immunol Ther Exp (Warsz). 2013;61:85-93.
• 5. Malphettes M, Gerard L, Galicier L, et al. Good Syndrome: an adult onset immune deficiency remarkable for its high incidence of invasive infections and autoimmune complications. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America. 2015.
• 6. Briones J, Iruretagoyena M, Galindo H, et al. Thymoma associated with hypogammaglobulinaemia and pure red cell aplasia. Ecancermedicalscience. 2013; 7:364.
• 7. Akinosoglou K, Melachrinou M, Siagris D, et al. Good’s syndrome and pure white cell aplasia complicated by cryptococcus infection: A case report and review of the literature. Journal of clinical immunology. 2014; 34: 283-288.
• 8. Bartlett MS, Smith JW. Pneumocystis carinii, an opportunist in immunocompromised patients. Clinical microbiology reviews. 1991;4:137-149.
• 9. Wang C-H, Chan ED, Perng C-L, et al. Intravenous immunoglobulin replacement therapy to prevent pulmonary infection in a patient with Good’s syndrome. Journal of Microbiology, Immunology and Infection. 2015; 48: 229-232.
• 10. Tarr PE, Sneller MC, Mechanic LJ, et al. Infections in patients with immunodeficiency with thymoma (Good syndrome). Report of 5 cases and review of the literature. Medicine. 2001; 80: 123-133.
• 11. Jensen ML, Bendstrup E, Hilberg O. Granulomatous-lymphocytic interstitial lung disease and recurrent sinopulmonary infections in a patient with Good’s syndrome. BMJ case reports. 2015; doi: 10.1136/bcr-2014-205635